Rossella Fioravanti

Pubblicazioni

Titolo Pubblicato in Anno
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity CHEMMEDCHEM 2020
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells CLINICAL EPIGENETICS 2019
design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol-4-yl-methylaniline derivatives FRONTIERS IN CHEMISTRY 2019
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype CLINICAL EPIGENETICS 2019
Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo MOLECULAR NEUROBIOLOGY 2019
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer CURRENT OPINION IN CHEMICAL BIOLOGY 2019
Six years (2012-2018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds THE CHEMICAL RECORD 2018
Inhibitors of yellow fever virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: design, synthesis and antiviral evaluation EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2017
(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2016
3-(Phenyl-4-oxy)-5-phenyl-4,5-dihydro-(1H)-pyrazole: a fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part I. Structure-enantioselectivity relationships JOURNAL OF CHROMATOGRAPHY A 2016
N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)anilines: a novel class of anti-RSV agents BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2015

ERC

  • PE5_18

KET

  • Life-science technologies & biotechnologies

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma